Surveillance in Barrett's esophagus: A failed premise

Keio Journal of Medicine

Volumn 58, Issue 1, 2009, Pages 12-18

  Inadomi, John M ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Barrett's esophagus; Esophageal adenocarcinoma; Screening; Surveillance

Indexed keywords

BIOLOGICAL MARKER;

BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DRUG SURVEILLANCE PROGRAM; ENDOSCOPIC MUCOSAL RESECTION; ESOPHAGEAL ADENOCARCINOMA; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; HELICOBACTER PYLORI; HUMAN; PHOTODYNAMIC THERAPY; RADIOFREQUENCY ABLATION; REVIEW; RISK FACTOR; SURVIVAL TIME;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; HUMANS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 65949121373     PISSN: 00229717     EISSN: 18801293     Source Type: Journal    
DOI: 10.2302/kjm.58.12     Document Type: Review

References (42)

1. Wang KK, Sampliner RE: Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus. Am J Gastroenterol 2008; 103: 788-797
2. Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG: Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989; 96: 1249-1256 (Pubitemid 19126659)
3. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS: Is there publication bias in the reporting of cancer risk in Barrett's esophagus-Gastroenterology 2000; 119: 333-338
4. Schnell TG, Sontag SJ, Chejfec G, Aranha G, Metz A, O'Connell S, Seidel UJ, Sonnenberg A: Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001; 120: 1607-1619 (Pubitemid 32523480)
5. Robertson CS, Mayberry JF, Nicholson DA, James PD, Atkinson M: Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg 1988; 75: 760-763 (Pubitemid 18199152)
6. Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC, Rabinovitch PS: Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 1992; 102: 1212-1219
7. Sharma P, Falk GW, Weston AP, Reker D, Johnston M, Sampliner RE: Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006; 4: 566-572 (Pubitemid 44308164)
8. el-Serag HB, Sonnenberg A: Opposing time trends of peptic ulcer and reflux disease. Gut 1998; 43: 327-333
9. Wang KK, Wongkeesong M, Buttar NS: American Gastroenterological Association technical review on the role of the gastroenterologist in the management of esophageal carcinoma. Gastroenterology 2005; 128: 1471-1505 (Pubitemid 40712197)
10. Wang KK, Wongkeesong M, Buttar NS: American Gastroenterological Association medical position statement: Role of the gastroenterologist in the management of esophageal carcinoma. Gastroenterology 2005; 128: 1468-1470 (Pubitemid 40712196)
11. Buttar NS, Wang KK, Lutzke LS, Krishnadath KK, Anderson MA: Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Gastrointest Endosc 2001; 54: 682-688 (Pubitemid 33668674)
12. Pacifico RJ, Wang KK, Wongkeesong LM, Buttar NS, Lutzke LS: Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus. Clin Gastroenterol Hepatol 2003; 1: 252-257 (Pubitemid 37254451)
13. Streitz JM Jr, Andrews CW Jr, Ellis FH Jr.: Endoscopic surveillance of Barrett's esophagus. Does it help? J Thorac Cardiovasc Surg 1993; 105: 383-387
14. Peters JH, Clark GW, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR: Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994; 108: 813-821 (Pubitemid 24351664)
15. van Sandick JW, van Lanschot JJ, Kuiken BW, Tytgat GN, Offerhaus GJ, Obertop H: Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 1998; 43: 216-222 (Pubitemid 28348324)
16. Corley DA, Levin TR, Habel LA, Weiss NS, Buffler PA: Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology 2002; 122: 633-640 (Pubitemid 34173814)
17. Rubenstein JH, Sonnenberg A, Davis J, McMahon L, Inadomi JM: Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans. Gastrointestinal Endoscopy 2008; 65: 849-855
18. Inadomi JM, Sampliner R, Lagergren J, Lieberman D, Fendrick AM, Vakil N: Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med 2003; 138: 176-186 (Pubitemid 36231623)
19. Lagergren J, Bergstrom R, Lindgren A, Nyren O: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-831 (Pubitemid 29142625)
20. Spechler SJ, Goyal RK: Barrett's esophagus. N Engl J Med 1986; 315: 362-371 (Pubitemid 16060091)
21. Cameron AJ: Epidemiologic studies and the development of Barrett's esophagus. Endoscopy 1993; 25: 635-636 (Pubitemid 24002745)
22. Weston AP, Krmpotich P, Makdisi WF, Cherian R, Dixon A, McGregor DH, Banerjee SK: Short segment Barrett's esophagus: clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia. Am J Gastroenterol 1996; 91: 981-986 (Pubitemid 26143539)
23. Gerson LB, Shetler K, Triadafilopoulos G: Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002; 123: 461-467
24. Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, Van Belle G, Lewin K, Weinstein WM, Antonioli DA, Goldman H, et al.: Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988; 19: 166-178
25. Reid BJ, Blount PL, Rabinovitch PS: Biomarkers in Barrett's esophagus. Gastrointest Endosc Clin N Am 2003; 13: 369-397 (Pubitemid 36605251)
26. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB: Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996; 276: 1253-1258 (Pubitemid 26337709)
27. Gold MR, Siegel JE, Russell LB, Weinstein MC: Cost-effectiveness in health and medicine. ed. New York: Oxford University Press, 1996
28. Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS: Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol 2000; 95: 1669-1676 (Pubitemid 30485000)
29. Rubenstein JH, Vakil N, Inadomi JM: The cost-effectiveness of biomarkers for predicting the development of oesophageal adenocarcinoma. Aliment Pharmacol Ther 2005; 22: 135-146 (Pubitemid 41039702)
30. Vij R, Triadafilopoulos G, Owens DK, Kunz P, Sanders GD: Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. Gastrointestinal Endoscopy 2004; 60: 739-756 (Pubitemid 39550931)
31. Shaheen NJ, Inadomi JM, Overholt BF, Sharma P: What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis. Gut 2004; 53: 1736-1744 (Pubitemid 39556888)
32. Hur C, Nishioka NS, Gazelle GS: Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia. Digestive Diseases & Sciences 2003; 48: 1273-1283
33. Comay D, Blackhouse G, Goeree R, Armstrong D, Marshall JK: Photodynamic therapy for Barrett's esophagus with high-grade dysplasia: a cost-effectiveness analysis. Can J Gastroenterol 2007; 21: 217-222 (Pubitemid 46915840)
34. Sharma VK, Wang KK, Overholt BF, Lightdale CJ, Fennerty MB, Dean PJ, Pleskow DK, Chuttani R, Reymunde A, Santiago N, Chang KJ, Kimmey MB, Fleischer DE: Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 2007; 65: 185-195 (Pubitemid 46157125)
35. Roorda AK, Marcus SN, Triadafilopoulos G: Early experience with radiofrequency energy ablation therapy for Barrett's esophagus with and without dysplasia. Dis Esophagus 2007; 20: 516-522 (Pubitemid 47617837)
36. Gondrie JJ, Pouw RE, Sondermeijer CMT, Peters FP, Curvers WL, Rosmolen WD, Ten Kate F, Fockens P, Bergman JJ. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy 2008; 40: 370-379
37. Gondrie JJ, Pouw RE, Sondermeijer CMT, Peters FP, Curvers WL, Rosmolen WD, Ten Kate F, Fockens P, Bergman JJ: Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy 2008; 40: 359-369
38. Fleischer DE , Overholt BF, Sharma VK, Reymunde A, Kimmey MB, Chuttani R, Chang KC, Lightdale CJ, Santiago N, Pleskow DK, Dean PJ, Wang KK: Endoscopic ablation of Barrett's esophagus: A multi-center study with 2.5-year follow-up. Gastrointestinal Endoscopy 2008; 68: 867-876
39. Ell C, May A, Gossner L, Pech O, Gunter E, Mayer G, Henrich R, Vieth M, Muller H, Seitz G, Stolte M: Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000; 118: 670-677 (Pubitemid 30171616)
40. Ell C, May A, Pech O, Gossner L, Guenter E, Behrens A, Nachbar L, Huijsmans J, Vieth M, Stolte M: Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc 2007; 65: 3-10
41. Lopes CV, Hela M, Pesenti C, Bories E, Caillol F, Monges G, Giovannini M: Circumferential endoscopic resection of Barrett's esophagus with high-grade dysplasia or early adenocarcinoma. Surg Endosc 2007; 21: 820-824 (Pubitemid 46675513)
42. May A, Gossner L, Pech O, Muller H, Vieth M, Stolte M, Ell C: Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): curative treatment using local endoscopic treatment techniques. Endoscopy 2002; 34: 604-610